Six Pivotal Developments in Stroke Treatment and Care

Illustration by Jeannie Phan
The Calgary Stroke Program is an incubator for research breakthroughs and developments that have led to transformative methods for diagnosis, treatments and therapies from game-changing clot-busting drugs and stroke-assessment tools to life-altering treatments and rehabilitation technologies.

Written by Jennifer Myers, BA’97

In 1993, American neurologist Dr. Camilo Gomez, MD, coined the phrase, “time is brain!” With the discovery of a new medication that a U.S. trial later found to dissolve blood clots in the brain – the primary cause of ischemic strokes – neurologists worldwide had begun to understand that strokes could be treated, with improved outcomes and reduced long-term disability, if treatment occurred within a few hours of onset of symptoms.

It was a critical turning point in stroke care and paved the way for a profusion of research-backed breakthroughs and developments in diagnostic methods and treatments, as well as rehabilitation technologies. Since then, incredible advances have been made at the University of Calgary’s Cumming School of Medicine (CSM), where the Calgary Stroke Program (CSP) has revolutionized the treatment of stroke. CSP is a collaboration between the CSM’s Hotchkiss Brain Institute, the Department of Clinical Neurosciences and Alberta Health Services (AHS).

The need is pressing. According to Heart & Stroke, in Canada alone more than 100,000 strokes occur annually, and 878,000 Canadians live daily with the after-effects. CSP is both extending life and improving quality of life for stroke survivors every single day.

Evaluating Brain Imaging for Stroke – Fast

Ask a stroke neurologist about a patient in the Emergency Department and the first thing they want to know is their ASPECTS score. The Alberta Stroke Program Early CT Score (ASPECTS) is a 10-point grading system based on an evaluation of a brain CT scan. It helps doctors detect changes in a person’s brain early on in the process of a stroke. Developed and trialled at UCalgary, the tool is now the standard way that the changes on a CT scan in a patient presenting with symptoms of an acute stroke are measured worldwide. The team from UCalgary also run a training platform to train young physicians from across the world.

Image courtesy of Alberta Stroke Program.

Clot-Busting Drug, Tenecteplase, Becomes Standard Treatment for Stroke

Image of a clot removed from a person who has experienced a stroke. Photograph by Quentin Collier.

In 2022 researchers released findings from the largest acute stroke clinical trial ever run in Canada. A clot-busting drug called Tenecteplase (TNKase™), which is commonly used as a clot-buster for heart attacks, was tested against Alteplase (Activase™), the standard recommended drug for people with acute ischemic stroke. The AcT (Alteplase Compared to Tenecteplase) Trial found that Tenecteplase treatment was as good and probably slightly better at dissolving blood clots in brain arteries with greater efficiency and ease of administration, resulting in as good and slightly better clinical outcomes at 3 months after stroke. The drug is a game-changer in saving brain cells quickly after the onset of a stroke. It is now the standard of care or becoming the standard of care in Canada and elsewhere around the world.

Improved Stroke Imaging Technology Set to Speed Diagnosis, Treatment and Create Accessibility

UCalgary researchers have developed a prototype imaging technique that has potential to reduce the time and the need for people to undergo multiple scans or contrast dye injections involved in diagnosing stroke. Simple Perfusion Reconstruction Algorithm (SPIRAL) measures blood flow in the brain and provides detailed images of the blockages. Simplifying stroke imaging with SPIRAL can quicken the diagnostic process and make it more cost-effective, as well as make stroke imaging accessible in smaller communities.

Image of the scan of one side of the brain after reperfusion, where blood was blocked but is now circulating through the brain once again. Image courtesy of Calgary Stroke Program.

A Bio-Resorbable Stent to Heal Brain Aneurysms

The world’s first neurovascular stent constructed with bio-resorbable polymer was developed by Fluid Biomed, a medical device company founded by UCalgary researchers who are also academic neurosurgeons. Implanted into a brain blood vessel, the stent diverts blood flow away from a weak aneurysm thus allowing it to heal over time. As opposed to all-metal stents, most of the Fluid Biomed stent is made of a flexible polymer so that many more kinds of aneurysms can be treated with greater efficiency, and the polymer will gradually absorb into the body after the aneurysm is cured. The stent is already being tested in a first-in-human clinical trial and interim results are very promising.

Computer generated image of a polymer-based flow-diverting stent at work. Image courtesy of Fluid Biomed.

Research Network Develops Rehabilitative Treadmill

People with a neurological injury are benefiting from the Neuro RecoVR Treadmill Project to help restore their mobility. It’s a rehabilitation activity in which their gait is recorded while they walk on a split-belt treadmill with integrated virtual reality (VR) screens. The operator can place virtual obstacles in front of them and measure how they respond. The project is a part of RESTORE (REsearching STrategies fOr REhabilitation), a network of specialized academic and clinical experts from CSM and AHS who together create novel therapies, clinical trials, and technologies for people recovering from stroke or who have other movement impairments or spinal cord injuries.

Dr. Sean Dukelow, MD, PhD, (white coat), observes a study participant on the rehabilitative treadmill. Photograph by Riley Brandt.

VR and Robotics Create Personalized Rehabilitation Programs

Understanding how we learn motor skills is key to understanding how to re-learn them after damage to the brain caused by a stroke. Researchers developed the Kinarm, an exoskeleton robot, that helps us do just that. While a person sits in the exoskeleton and performs tasks in a VR environment, the Kinarm measures how healthy people and those recovering from stroke respond to a variety of challenges. While Kinarm was build and developed in Kingston, Ontario, UCalgary researchers are using it to develop personalized strategies for brain recovery for people who have had a stroke.

Dr. Tyler Cluff, PhD, Assistant Professor, Faculty of Kinesiology, working with the Kinarm. Photograph by Riley Brandt.
Ischemic stroke, the most common kind of stroke, is caused by a blood clot blocking flow of blood within the brain. While age is a risk factor for stroke, a stroke can happen to anyone of any age.

Learn More About Stroke

Illustration by Jeannie Phan

Good Fellows

Illustration by Jeannie Phan

From Trial to Triumph

You May Also Like
Drawing of girl's face suffering from migraine
Read More

9 Things to Know About Kids and Migraine

The potentially debilitating disorder is more common in kids than you might think and less researched than we want. A UCalgary researcher is changing the latter and shares some of what she has learned.
Read More

Better Aging with Pets

Should animal companionship — a proven boon for older adults — be a privilege or a health-care imperative?
Read More

Reshaping the Learning Landscape for Indigenous Children

For parents in a northern Alberta community, it feels as though their school division is embarking on a new era, one in which the needs of their children will be placed front-and-centre in determining the direction of their educational journey. For them, and for their Indigenous communities, this is no small thing.